Phase III Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

• Status: RECRUITING
• Trial end date: 2025-12-01

Summary

The purpose of the study is to evaluate the efficacy and safety of SHR-2004 in preventing venous thromboembolism after elective unilateral total knee arthroplasty.

• Phase: PHASE3

Details

• Lead Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
• Treatments: enoxaparin sodium